Cargando…
The hyper-activation of transcriptional enhancers in breast cancer
BACKGROUND: Activation of transcription enhancers, especially super-enhancers, is one of the critical epigenetic features of tumorigenesis. However, very few studies have systematically identified the enhancers specific in cancer tissues. METHODS: Here, we studied the change of histone modifications...
Autores principales: | Li, Qing-Lan, Wang, Dan-Ya, Ju, Lin-Gao, Yao, Jie, Gao, Chuan, Lei, Pin-Ji, Li, Lian-Yun, Zhao, Xiao-Lu, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417266/ https://www.ncbi.nlm.nih.gov/pubmed/30867030 http://dx.doi.org/10.1186/s13148-019-0645-x |
Ejemplares similares
-
Regulation of KDM5C stability and enhancer reprogramming in breast cancer
por: Xiao, Qiong, et al.
Publicado: (2022) -
GLIS2 promotes colorectal cancer through repressing enhancer activation
por: Yao, Jie, et al.
Publicado: (2020) -
Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma
por: Wang, Chen-Yu, et al.
Publicado: (2021) -
Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer
por: Wang, Hui-Yi, et al.
Publicado: (2019) -
HyperCys: A Structure- and Sequence-Based Predictor of Hyper-Reactive Druggable Cysteines
por: Gao, Mingjie, et al.
Publicado: (2023)